Absolute oral bioavailability of selexipag, a novel oral prostacyclin IP receptor agonist, in healthy subjects

Authors
Category Primary study
ConferenceClinical Pharmacology in Drug Development
Year 2016
This article has no abstract
Epistemonikos ID: a691cb6393cb10e1c93601feb2ba8070862d7de5
First added on: Apr 29, 2026